Abstract: Disclosed are systems and methods for diagnosing website quality. The method can include analyzing, by a computing system, a website to determine a current value for a quality score of the website, identifying issues with the website, providing information to cause a client device to present: (i) a circle graphical element that indicates the current value, a first portion of the circle's circumference being a size that indicates the current value, and (ii) indications of categories of issues with the website that each include different sets of issues, receiving an indication that user input at the client device selected a user-selected category, determining a target value for the quality score that would result should all issues within the user-selected category be resolved, and providing information to cause the client device to add a target element at a location on the circle's circumference that represents the target value.

Abstract: The present invention relates to a type XVI collagen assay and its use in evaluating diseases associated with type XVI collagen, in particular colorectal cancer and ulcerative colitis, and for identifying a subgroup of patients with Crohn’s disease that have (or are likely to develop) fibrostenotic strictures.

Abstract: Disclosed herein are immunoassay methods for detecting and quantifying human neutrophil elastase (HNE) generated fragments of calprotectin in a biofluid sample; and monoclonal antibodies and assay kits for use in such methods. The methods may be used for detecting, monitoring and/or determining the status or severity of a disease characterized by or exhibiting inflammation in a patient.

Abstract: Disclosed are systems and methods for diagnosing website quality. The method can include analyzing, by a computing system, a website to determine a current value for a quality score of the website, identifying issues with the website, providing information to cause a client device to present: (i) a circle graphical element that indicates the current value, a first portion of the circle's circumference being a size that indicates the current value, and (ii) indications of categories of issues with the website that each include different sets of issues, receiving an indication that user input at the client device selected a user-selected category, determining a target value for the quality score that would result should all issues within the user-selected category be resolved, and providing information to cause the client device to add a target element at a location on the circle's circumference that represents the target value.

Abstract: Disclosed are systems and methods for diagnosing website quality. The method can include analyzing, by a computing system, a website to determine a current value for a quality score of the website, identifying issues with the website, providing information to cause a client device to present: (i) a circle graphical element that indicates the current value, a first portion of the circle's circumference being a size that indicates the current value, and (ii) indications of categories of issues with the website that each include different sets of issues, receiving an indication that user input at the client device selected a user-selected category, determining a target value for the quality score that would result should all issues within the user-selected category be resolved, and providing information to cause the client device to add a target element at a location on the circle's circumference that represents the target value.

Abstract: The present invention relates to a type XVI collagen assay and its use in evaluating diseases associated with type XVI collagen, in particular colorectal cancer and ulcerative colitis, and for identifying a subgroup of patients with Crohn's disease that have (or are likely to develop) fibrostenotic strictures.

Abstract: The present disclosure relates to methods for reducing the rate of cardiovascular death, myocardial infarction, or stroke in a patient in recognized need thereof, comprising administering to the patient a pharmaceutical composition comprising 60 mg ticagrelor twice daily.

Abstract: The present disclosure relates to methods for reducing the rate of cardiovascular death, myocardial infarction, or stroke in a patient in recognized need thereof, comprising administering to the patient a pharmaceutical composition comprising 60 mg ticagrelor twice daily.